Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Medicine and Dentistry
Pediatrics
100%
Ganglioglioma
74%
Neoplasm
45%
Malignant Neoplasm
24%
Central Nervous System Tumor
22%
Medicine
21%
Clinical Trial
17%
Pediatric Brain Tumor
16%
Tumor Immune Microenvironment
15%
Tumor
14%
Personalized Medicine
14%
Childhood Cancer
11%
Pilocytic Astrocytoma
11%
Survival Rate
10%
RNA Sequence
10%
Cancer Susceptibility
9%
Adolescence
9%
Oncolytic Virus
9%
Microbiome
8%
Endopeptidase Clp
8%
Medulloblastoma
8%
Cancer
8%
Cancer Registry
8%
Oncolytic Adenovirus
8%
Immunohistochemistry
8%
Cancer Cell
7%
Cell Survival
7%
Open Reading Frame
7%
Gene Expression
7%
Oncology
7%
Central Nervous System
7%
Pontine Glioma
7%
Immunity
7%
School Attendance
7%
Biopsy Technique
7%
Natural Killer Cell Mediated Cytotoxicity
7%
Immunotherapy Clinical Trial
7%
Long Term Survival
7%
Adaptive Radiotherapy
7%
Precision Oncology
7%
Arm
6%
Adverse Event
6%
Pediatric Cancer
5%
Flow Cytometry
5%
Immunotherapy
5%
Keyphrases
Pediatric
28%
RNA Sequencing (RNA-seq)
21%
Pediatric Brain Tumor
19%
Tumor
16%
Oncolytic Virus
16%
Clinical Practice
15%
Pediatric Glioma
15%
Children with Cancer
14%
Childhood Cancer
14%
Population-based Study
14%
Personalized Therapy
14%
Cancer Program
14%
Precision Oncology
14%
High Risk
11%
Tumor Immune Microenvironment
10%
Relapsed or Refractory
10%
Netherlands
8%
Pediatric Oncology
7%
Combination Strategy
7%
Ependymoma
7%
Fusion Partner
7%
Quality of Survival
7%
Measuring Quality
7%
International Consensus
7%
Consensus Statement
7%
Survival Mechanism
7%
Population-based Cohort Study
7%
Sex-related
7%
Upstream Open Reading Frame (uORF)
7%
Survival Disparities
7%
Gene Expression Profile
7%
Heterogeneous Susceptibility
7%
Glioma Subtypes
7%
Unique Genes
7%
Childhood Medulloblastoma
7%
Cancer Cell Survival
7%
Non-canonical
7%
Survival Outcomes
7%
Immune Landscape
7%
Cancer Diagnostics
7%
Gene Fusion Detection
7%
Central Nervous System Malignancies
7%
DNX-2401
7%
Oncolytic
7%
Astroblastoma
7%
CXXC5
7%
BRAF Inhibitor (BRAFi)
7%
RNA-DNA
7%
Dasatinib
7%
Preadolescent children
7%
Immunology and Microbiology
RNA Sequence
21%
Immunotherapy
19%
Oncolytic Virus
18%
Immunocompetent Cell
18%
Immune Landscape
16%
Tumor Cell
14%
Gene Expression
14%
T Cell
14%
Overall Survival
14%
Immune Response
11%
Immunofluorescence
10%
Central Nervous System
10%
Oncolytic Adenovirus
10%
In Vitro
9%
Mortality Rate
8%
Virotherapy
7%
Germ Cell
7%
Sex Differences
7%
Microglia
7%
Glycoprotein
7%
DNA Damage
7%
Co-Stimulation
7%
T Cell Receptor
7%
Sturgeon
7%
Tumor Classification
7%
Cytotoxic T-Cell
7%
Tumor Volume
7%
Whole Exome Sequencing
7%
Natural Killer Cell Mediated Cytotoxicity
7%
CD155
7%
Survival Rate
7%
Microbiome
7%
Chimeric Antigen Receptor T-Cell
7%
Gut Microbiome
7%
Tumor-Infiltrating Lymphocytes
7%
Immunological Memory
7%
Macrophage
7%
Immunity
5%